| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia | 42 | 2023 | 325 | 10.000 |
Why?
|
| Community-Acquired Infections | 39 | 2023 | 240 | 8.320 |
Why?
|
| Streptococcus pneumoniae | 75 | 2022 | 371 | 8.030 |
Why?
|
| Pneumonia, Pneumococcal | 37 | 2019 | 82 | 8.020 |
Why?
|
| Pneumococcal Infections | 47 | 2016 | 274 | 5.700 |
Why?
|
| Anti-Bacterial Agents | 76 | 2024 | 2381 | 5.310 |
Why?
|
| Pneumococcal Vaccines | 32 | 2016 | 169 | 5.260 |
Why?
|
| Pneumonia, Bacterial | 12 | 2022 | 77 | 4.710 |
Why?
|
| Antibodies, Bacterial | 43 | 2017 | 384 | 3.450 |
Why?
|
| Enterocolitis, Pseudomembranous | 13 | 2016 | 93 | 3.130 |
Why?
|
| Bacteremia | 22 | 2024 | 405 | 3.130 |
Why?
|
| Staphylococcal Infections | 29 | 2017 | 550 | 2.560 |
Why?
|
| Polysaccharides, Bacterial | 17 | 2023 | 67 | 2.540 |
Why?
|
| Syphilis | 37 | 2019 | 95 | 2.290 |
Why?
|
| Neurosyphilis | 9 | 2024 | 14 | 2.180 |
Why?
|
| Sputum | 11 | 2023 | 112 | 2.090 |
Why?
|
| Immunoglobulin G | 31 | 2017 | 775 | 1.970 |
Why?
|
| Humans | 363 | 2024 | 121933 | 1.970 |
Why?
|
| Staphylococcus aureus | 29 | 2017 | 458 | 1.950 |
Why?
|
| Osteomyelitis | 17 | 2022 | 202 | 1.920 |
Why?
|
| Bacteriology | 2 | 2023 | 4 | 1.700 |
Why?
|
| Bacterial Infections | 16 | 2018 | 304 | 1.630 |
Why?
|
| Myocardial Infarction | 10 | 2022 | 992 | 1.570 |
Why?
|
| Ceftriaxone | 9 | 2024 | 68 | 1.490 |
Why?
|
| Bacterial Vaccines | 20 | 1999 | 101 | 1.460 |
Why?
|
| Vaccines, Conjugate | 8 | 2016 | 78 | 1.350 |
Why?
|
| Haemophilus Infections | 14 | 2019 | 91 | 1.260 |
Why?
|
| Clostridium Infections | 5 | 2012 | 230 | 1.260 |
Why?
|
| Penicillins | 9 | 2024 | 154 | 1.200 |
Why?
|
| Methicillin Resistance | 11 | 2008 | 117 | 1.170 |
Why?
|
| Aged | 79 | 2019 | 18505 | 1.160 |
Why?
|
| Thiazoles | 4 | 2009 | 96 | 1.120 |
Why?
|
| Male | 182 | 2019 | 59266 | 1.120 |
Why?
|
| Middle Aged | 110 | 2018 | 25447 | 1.090 |
Why?
|
| Haemophilus influenzae | 20 | 2009 | 130 | 1.090 |
Why?
|
| Anti-Infective Agents | 5 | 2015 | 266 | 1.070 |
Why?
|
| Pneumonia, Viral | 5 | 2022 | 377 | 0.980 |
Why?
|
| Macrolides | 6 | 2019 | 28 | 0.960 |
Why?
|
| Adult | 114 | 2023 | 28681 | 0.960 |
Why?
|
| Endocarditis | 5 | 2020 | 103 | 0.950 |
Why?
|
| Severity of Illness Index | 14 | 2019 | 2799 | 0.940 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 594 | 0.930 |
Why?
|
| Drug Utilization | 3 | 2016 | 157 | 0.910 |
Why?
|
| Terminology as Topic | 3 | 2024 | 222 | 0.890 |
Why?
|
| Communicable Diseases | 2 | 2022 | 163 | 0.880 |
Why?
|
| Treponema pallidum | 25 | 2019 | 49 | 0.880 |
Why?
|
| Salmonella Infections | 3 | 2013 | 30 | 0.870 |
Why?
|
| Metronidazole | 5 | 2007 | 154 | 0.860 |
Why?
|
| Nucleic Acids | 1 | 2023 | 23 | 0.850 |
Why?
|
| Hospitalization | 14 | 2022 | 1724 | 0.840 |
Why?
|
| Cross Infection | 11 | 2012 | 331 | 0.840 |
Why?
|
| Microbial Sensitivity Tests | 21 | 2014 | 793 | 0.820 |
Why?
|
| Meningococcal Vaccines | 3 | 2008 | 30 | 0.820 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 5 | 2014 | 220 | 0.810 |
Why?
|
| Streptococcus | 7 | 2009 | 61 | 0.770 |
Why?
|
| Bacterial Toxins | 5 | 2007 | 176 | 0.770 |
Why?
|
| Bacteria | 13 | 2023 | 478 | 0.770 |
Why?
|
| Female | 97 | 2019 | 64626 | 0.760 |
Why?
|
| Lipoproteins | 3 | 2016 | 179 | 0.750 |
Why?
|
| Laboratories | 1 | 2021 | 83 | 0.730 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 4 | 2015 | 25 | 0.730 |
Why?
|
| Respiratory Tract Infections | 7 | 2018 | 263 | 0.720 |
Why?
|
| Vancomycin | 9 | 2012 | 216 | 0.720 |
Why?
|
| Aged, 80 and over | 30 | 2018 | 6103 | 0.720 |
Why?
|
| Vaccination | 17 | 2016 | 925 | 0.700 |
Why?
|
| Polymerase Chain Reaction | 9 | 2016 | 1591 | 0.700 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 89 | 0.700 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 93 | 0.700 |
Why?
|
| Fever | 7 | 2017 | 295 | 0.690 |
Why?
|
| Bacterial Proteins | 10 | 2012 | 872 | 0.690 |
Why?
|
| Abscess | 9 | 2008 | 138 | 0.690 |
Why?
|
| HIV Infections | 20 | 2011 | 1865 | 0.680 |
Why?
|
| Oral Ulcer | 1 | 2019 | 4 | 0.680 |
Why?
|
| Bacterial Capsules | 10 | 2000 | 37 | 0.670 |
Why?
|
| Coinfection | 1 | 2021 | 170 | 0.670 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2012 | 146 | 0.670 |
Why?
|
| Urinary Tract Infections | 12 | 2012 | 290 | 0.660 |
Why?
|
| Protective Clothing | 1 | 2019 | 7 | 0.660 |
Why?
|
| Health Occupations | 1 | 2019 | 21 | 0.650 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 262 | 0.630 |
Why?
|
| Rhodococcus equi | 1 | 2018 | 4 | 0.620 |
Why?
|
| Immunization Schedule | 4 | 2016 | 102 | 0.620 |
Why?
|
| Actinomycetales Infections | 1 | 2018 | 12 | 0.620 |
Why?
|
| Documentation | 1 | 2019 | 115 | 0.620 |
Why?
|
| Gram-Positive Bacteria | 2 | 2011 | 46 | 0.610 |
Why?
|
| Streptococcal Infections | 12 | 2001 | 243 | 0.600 |
Why?
|
| Gram-Negative Bacteria | 2 | 2011 | 66 | 0.600 |
Why?
|
| Staphylococcus | 9 | 2010 | 68 | 0.590 |
Why?
|
| Virus Diseases | 3 | 2013 | 279 | 0.590 |
Why?
|
| AIDS-Related Opportunistic Infections | 5 | 2018 | 139 | 0.580 |
Why?
|
| Rickettsia typhi | 1 | 2017 | 12 | 0.580 |
Why?
|
| Antigen-Antibody Complex | 9 | 2001 | 80 | 0.580 |
Why?
|
| Phagocytosis | 21 | 2008 | 175 | 0.570 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2017 | 19 | 0.570 |
Why?
|
| Acute Disease | 16 | 2019 | 1086 | 0.560 |
Why?
|
| Blood | 6 | 2013 | 106 | 0.560 |
Why?
|
| Treatment Outcome | 19 | 2016 | 11702 | 0.550 |
Why?
|
| Acute Coronary Syndrome | 2 | 2010 | 197 | 0.550 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 2016 | 37 | 0.550 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2013 | 710 | 0.550 |
Why?
|
| Enterotoxins | 2 | 2007 | 83 | 0.550 |
Why?
|
| Lung Diseases, Obstructive | 2 | 2016 | 34 | 0.550 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2018 | 201 | 0.530 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 665 | 0.530 |
Why?
|
| Secondary Prevention | 2 | 2016 | 209 | 0.530 |
Why?
|
| Spores, Bacterial | 1 | 2016 | 21 | 0.520 |
Why?
|
| Immunization, Secondary | 4 | 2016 | 105 | 0.520 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2014 | 74 | 0.520 |
Why?
|
| Cognition | 1 | 2020 | 733 | 0.510 |
Why?
|
| Serotyping | 11 | 2016 | 179 | 0.510 |
Why?
|
| Anemia | 3 | 2011 | 338 | 0.500 |
Why?
|
| Bacteriuria | 5 | 2013 | 82 | 0.500 |
Why?
|
| Disease Outbreaks | 6 | 2009 | 318 | 0.500 |
Why?
|
| Influenza, Human | 2 | 2021 | 646 | 0.490 |
Why?
|
| Leukocytosis | 3 | 2006 | 42 | 0.490 |
Why?
|
| Aerococcus | 1 | 2014 | 1 | 0.490 |
Why?
|
| Sinusitis | 4 | 2007 | 117 | 0.480 |
Why?
|
| Penicillin Resistance | 9 | 2006 | 80 | 0.480 |
Why?
|
| Sepsis | 17 | 2024 | 471 | 0.480 |
Why?
|
| Retrospective Studies | 24 | 2022 | 15630 | 0.470 |
Why?
|
| Risk Factors | 20 | 2019 | 9686 | 0.460 |
Why?
|
| Disease Progression | 2 | 2019 | 1972 | 0.460 |
Why?
|
| Syphilis Serodiagnosis | 6 | 2008 | 14 | 0.460 |
Why?
|
| Developed Countries | 1 | 2014 | 34 | 0.460 |
Why?
|
| Rickettsia Infections | 2 | 2004 | 6 | 0.460 |
Why?
|
| Rickettsia | 2 | 2004 | 11 | 0.460 |
Why?
|
| Time Factors | 25 | 2014 | 5997 | 0.460 |
Why?
|
| Necrosis | 4 | 2011 | 212 | 0.450 |
Why?
|
| Salmonella enteritidis | 2 | 2013 | 6 | 0.450 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2013 | 1980 | 0.430 |
Why?
|
| Aneurysm, Infected | 1 | 2013 | 22 | 0.430 |
Why?
|
| Hospitals, Veterans | 5 | 2011 | 353 | 0.430 |
Why?
|
| Vasculitis | 2 | 2012 | 48 | 0.420 |
Why?
|
| Hepatitis C | 1 | 2017 | 368 | 0.420 |
Why?
|
| Incidence | 12 | 2017 | 2997 | 0.420 |
Why?
|
| Bacterial Typing Techniques | 2 | 2010 | 100 | 0.420 |
Why?
|
| Physicians | 1 | 2019 | 581 | 0.410 |
Why?
|
| Mountaineering | 1 | 2012 | 1 | 0.410 |
Why?
|
| Electronic Health Records | 1 | 2019 | 689 | 0.410 |
Why?
|
| Endocarditis, Bacterial | 9 | 2007 | 129 | 0.410 |
Why?
|
| Virulence | 16 | 2012 | 259 | 0.410 |
Why?
|
| Nail Diseases | 1 | 2012 | 14 | 0.400 |
Why?
|
| Prospective Studies | 23 | 2016 | 5912 | 0.400 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 1242 | 0.400 |
Why?
|
| Syphilis, Cutaneous | 3 | 2011 | 4 | 0.400 |
Why?
|
| Polysaccharides | 5 | 2018 | 142 | 0.400 |
Why?
|
| Immunocompromised Host | 4 | 2020 | 300 | 0.400 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2012 | 43 | 0.390 |
Why?
|
| Streptolysins | 4 | 2001 | 10 | 0.390 |
Why?
|
| Catheter-Related Infections | 3 | 2012 | 129 | 0.390 |
Why?
|
| Viruses | 1 | 2013 | 123 | 0.390 |
Why?
|
| Aneurysm, False | 1 | 2013 | 97 | 0.390 |
Why?
|
| Azithromycin | 1 | 2011 | 45 | 0.390 |
Why?
|
| Comorbidity | 8 | 2016 | 1479 | 0.380 |
Why?
|
| Animals | 68 | 2022 | 33736 | 0.380 |
Why?
|
| Sensitivity and Specificity | 11 | 2015 | 2008 | 0.370 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2012 | 142 | 0.370 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 633 | 0.370 |
Why?
|
| Texas | 9 | 2017 | 3526 | 0.360 |
Why?
|
| Thinness | 1 | 2010 | 68 | 0.350 |
Why?
|
| Immunoglobulin M | 8 | 2017 | 221 | 0.350 |
Why?
|
| Immunologic Factors | 1 | 2011 | 176 | 0.340 |
Why?
|
| Rabbits | 29 | 2006 | 723 | 0.340 |
Why?
|
| Intensive Care Units | 5 | 2016 | 474 | 0.340 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 277 | 0.330 |
Why?
|
| Prognosis | 10 | 2020 | 4485 | 0.330 |
Why?
|
| Suction | 2 | 2006 | 56 | 0.330 |
Why?
|
| Pyelonephritis | 4 | 2006 | 27 | 0.330 |
Why?
|
| Colitis | 2 | 2009 | 153 | 0.330 |
Why?
|
| Fever of Unknown Origin | 3 | 2007 | 45 | 0.330 |
Why?
|
| United States | 18 | 2022 | 10434 | 0.330 |
Why?
|
| Pulmonary Emphysema | 2 | 2008 | 93 | 0.320 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2009 | 53 | 0.320 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 278 | 0.320 |
Why?
|
| Hemorrhage | 1 | 2012 | 457 | 0.310 |
Why?
|
| Psoas Abscess | 2 | 1998 | 3 | 0.310 |
Why?
|
| Peritonitis | 5 | 2006 | 76 | 0.300 |
Why?
|
| Leukocytes | 4 | 2007 | 209 | 0.300 |
Why?
|
| Calcitonin | 2 | 2020 | 31 | 0.300 |
Why?
|
| Lung Abscess | 3 | 2006 | 15 | 0.300 |
Why?
|
| Overweight | 1 | 2010 | 339 | 0.300 |
Why?
|
| History, 19th Century | 6 | 2021 | 118 | 0.300 |
Why?
|
| Nitro Compounds | 4 | 2009 | 18 | 0.300 |
Why?
|
| Hyperglycemia | 1 | 2009 | 221 | 0.300 |
Why?
|
| Antiparasitic Agents | 1 | 2007 | 31 | 0.300 |
Why?
|
| Antibody Formation | 6 | 2000 | 271 | 0.290 |
Why?
|
| Indium Radioisotopes | 1 | 2007 | 10 | 0.290 |
Why?
|
| Bacteriological Techniques | 4 | 2005 | 90 | 0.290 |
Why?
|
| Antigens, Bacterial | 11 | 2019 | 312 | 0.290 |
Why?
|
| Soft Tissue Infections | 2 | 2018 | 81 | 0.290 |
Why?
|
| Bone Diseases, Infectious | 1 | 2007 | 8 | 0.290 |
Why?
|
| Tomography, Emission-Computed | 1 | 2007 | 43 | 0.290 |
Why?
|
| Protein Precursors | 2 | 2020 | 150 | 0.290 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2007 | 8 | 0.290 |
Why?
|
| Gentamicins | 8 | 2004 | 95 | 0.280 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 268 | 0.280 |
Why?
|
| Feces | 4 | 2007 | 699 | 0.280 |
Why?
|
| Staphylococcus epidermidis | 2 | 1998 | 41 | 0.270 |
Why?
|
| Superantigens | 1 | 2006 | 19 | 0.270 |
Why?
|
| Pneumonia, Staphylococcal | 6 | 2019 | 18 | 0.270 |
Why?
|
| Immunity, Herd | 1 | 2006 | 12 | 0.270 |
Why?
|
| Urine | 7 | 2013 | 88 | 0.270 |
Why?
|
| Recurrence | 8 | 2007 | 1396 | 0.270 |
Why?
|
| Drug Therapy, Combination | 9 | 2019 | 1146 | 0.270 |
Why?
|
| Amoxicillin | 2 | 2005 | 118 | 0.270 |
Why?
|
| Clinical Trials as Topic | 3 | 2008 | 1082 | 0.260 |
Why?
|
| Blood Bactericidal Activity | 9 | 2006 | 18 | 0.260 |
Why?
|
| Macrophages | 12 | 1990 | 615 | 0.250 |
Why?
|
| Heptanoic Acids | 1 | 2006 | 77 | 0.250 |
Why?
|
| Fibronectins | 4 | 1996 | 111 | 0.250 |
Why?
|
| Diabetes Complications | 3 | 2013 | 196 | 0.250 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 349 | 0.250 |
Why?
|
| Conflict of Interest | 1 | 2006 | 67 | 0.250 |
Why?
|
| Ethics, Medical | 3 | 2019 | 395 | 0.250 |
Why?
|
| Risk Assessment | 6 | 2018 | 3223 | 0.250 |
Why?
|
| Survival Rate | 4 | 2018 | 1984 | 0.250 |
Why?
|
| Spinal Cord Injuries | 4 | 1997 | 301 | 0.250 |
Why?
|
| Emphysema | 1 | 2006 | 67 | 0.250 |
Why?
|
| Proton Pump Inhibitors | 1 | 2007 | 253 | 0.240 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 598 | 0.240 |
Why?
|
| Penicillin G Benzathine | 5 | 1992 | 18 | 0.240 |
Why?
|
| Splenectomy | 1 | 2005 | 60 | 0.240 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 1032 | 0.240 |
Why?
|
| DNA, Bacterial | 6 | 2006 | 480 | 0.240 |
Why?
|
| Age Factors | 9 | 2018 | 2771 | 0.240 |
Why?
|
| History, 20th Century | 4 | 2021 | 381 | 0.240 |
Why?
|
| Pyrroles | 1 | 2006 | 177 | 0.230 |
Why?
|
| Streptococcus pyogenes | 5 | 2003 | 77 | 0.230 |
Why?
|
| Bronchitis | 7 | 1990 | 34 | 0.230 |
Why?
|
| Urinary Catheterization | 5 | 2013 | 78 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 971 | 0.230 |
Why?
|
| Microscopy | 3 | 2021 | 119 | 0.230 |
Why?
|
| Doxycycline | 2 | 2023 | 117 | 0.230 |
Why?
|
| Empyema, Pleural | 2 | 2003 | 23 | 0.230 |
Why?
|
| Drug Administration Schedule | 4 | 2020 | 729 | 0.230 |
Why?
|
| Expeditions | 1 | 2003 | 5 | 0.230 |
Why?
|
| Tick-Borne Diseases | 1 | 2003 | 10 | 0.230 |
Why?
|
| Cause of Death | 2 | 2018 | 448 | 0.230 |
Why?
|
| Spinal Diseases | 4 | 2014 | 46 | 0.220 |
Why?
|
| Neutrophils | 10 | 2001 | 383 | 0.220 |
Why?
|
| Acquired Immunodeficiency Syndrome | 5 | 2007 | 235 | 0.220 |
Why?
|
| Allergy and Immunology | 2 | 2021 | 24 | 0.220 |
Why?
|
| Anticholesteremic Agents | 1 | 2006 | 230 | 0.220 |
Why?
|
| Immunologic Memory | 3 | 2021 | 180 | 0.220 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2002 | 1 | 0.210 |
Why?
|
| Otitis Media | 3 | 2000 | 82 | 0.210 |
Why?
|
| Drug Resistance, Multiple | 3 | 2000 | 50 | 0.210 |
Why?
|
| Carrier State | 5 | 2014 | 76 | 0.210 |
Why?
|
| Platelet Adhesiveness | 1 | 2002 | 40 | 0.210 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2003 | 268 | 0.200 |
Why?
|
| Case-Control Studies | 6 | 2010 | 3226 | 0.200 |
Why?
|
| Critical Care | 1 | 2008 | 647 | 0.200 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2022 | 11 | 0.200 |
Why?
|
| Phenazines | 4 | 2014 | 8 | 0.200 |
Why?
|
| Gentian Violet | 4 | 2014 | 8 | 0.200 |
Why?
|
| Administration, Intravenous | 2 | 2020 | 142 | 0.200 |
Why?
|
| Young Adult | 6 | 2017 | 8750 | 0.200 |
Why?
|
| Shock, Septic | 3 | 2022 | 148 | 0.200 |
Why?
|
| Platelet Aggregation | 1 | 2002 | 120 | 0.200 |
Why?
|
| Thrombophilia | 1 | 2002 | 40 | 0.200 |
Why?
|
| beta-Lactam Resistance | 2 | 2001 | 47 | 0.200 |
Why?
|
| Adolescent | 14 | 2017 | 18941 | 0.200 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 4990 | 0.200 |
Why?
|
| Hydroxyurea | 1 | 2002 | 81 | 0.200 |
Why?
|
| Haemophilus Vaccines | 2 | 2014 | 30 | 0.190 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 1283 | 0.190 |
Why?
|
| Ampicillin Resistance | 1 | 2001 | 17 | 0.190 |
Why?
|
| Penicillin G | 5 | 1995 | 19 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 2 | 2004 | 335 | 0.190 |
Why?
|
| Catheterization, Central Venous | 1 | 2002 | 131 | 0.190 |
Why?
|
| Colony Count, Microbial | 6 | 2012 | 89 | 0.190 |
Why?
|
| Carrier Proteins | 2 | 2016 | 1022 | 0.190 |
Why?
|
| Mice | 27 | 2017 | 17547 | 0.180 |
Why?
|
| Respiratory Syncytial Viruses | 3 | 2016 | 145 | 0.180 |
Why?
|
| Cough | 2 | 1995 | 87 | 0.180 |
Why?
|
| Catheterization | 2 | 2006 | 235 | 0.180 |
Why?
|
| Opsonin Proteins | 10 | 2000 | 22 | 0.180 |
Why?
|
| Cephalosporins | 5 | 2012 | 137 | 0.170 |
Why?
|
| Radiography, Thoracic | 3 | 2019 | 155 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2001 | 813 | 0.170 |
Why?
|
| Immunoglobulin Allotypes | 2 | 1997 | 6 | 0.170 |
Why?
|
| Tertiary Care Centers | 3 | 2018 | 228 | 0.170 |
Why?
|
| Lipopolysaccharides | 5 | 1998 | 290 | 0.170 |
Why?
|
| Patient Care Management | 1 | 2020 | 65 | 0.170 |
Why?
|
| Logistic Models | 5 | 2015 | 1759 | 0.170 |
Why?
|
| Viremia | 1 | 2020 | 128 | 0.170 |
Why?
|
| Palate, Hard | 1 | 2019 | 6 | 0.170 |
Why?
|
| Obesity | 1 | 2010 | 2082 | 0.170 |
Why?
|
| Receptors, IgG | 1 | 2000 | 57 | 0.170 |
Why?
|
| Drug Resistance, Microbial | 8 | 2002 | 193 | 0.170 |
Why?
|
| Fraud | 1 | 2019 | 16 | 0.170 |
Why?
|
| Immunodominant Epitopes | 2 | 1996 | 47 | 0.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2013 | 1815 | 0.170 |
Why?
|
| Laundering | 1 | 2019 | 1 | 0.170 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2020 | 87 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 2 | 1997 | 72 | 0.160 |
Why?
|
| Spinal Cord Diseases | 2 | 1992 | 38 | 0.160 |
Why?
|
| Aminoglycosides | 3 | 2012 | 44 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2011 | 315 | 0.160 |
Why?
|
| Mycobacterium kansasii | 1 | 1998 | 7 | 0.160 |
Why?
|
| Nasopharynx | 2 | 1997 | 80 | 0.160 |
Why?
|
| Hand Dermatoses | 1 | 1998 | 7 | 0.160 |
Why?
|
| Lung | 5 | 2018 | 1471 | 0.160 |
Why?
|
| Actinomycosis | 1 | 1998 | 7 | 0.160 |
Why?
|
| Troponin | 1 | 2019 | 70 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2006 | 358 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 5 | 2003 | 231 | 0.160 |
Why?
|
| Exanthema | 1 | 2019 | 68 | 0.160 |
Why?
|
| Cellulitis | 8 | 1992 | 64 | 0.150 |
Why?
|
| Research | 2 | 1999 | 260 | 0.150 |
Why?
|
| Physical Examination | 1 | 2019 | 162 | 0.150 |
Why?
|
| Streptococcus agalactiae | 2 | 1997 | 105 | 0.150 |
Why?
|
| Pharyngitis | 2 | 1997 | 31 | 0.150 |
Why?
|
| Thigh | 1 | 2018 | 49 | 0.150 |
Why?
|
| Hydroxamic Acids | 5 | 1976 | 57 | 0.150 |
Why?
|
| Nelfinavir | 1 | 1997 | 5 | 0.150 |
Why?
|
| Predictive Value of Tests | 6 | 2016 | 2059 | 0.150 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 1998 | 59 | 0.150 |
Why?
|
| Vibrio Infections | 4 | 1986 | 16 | 0.150 |
Why?
|
| Abdominal Wall | 1 | 2018 | 32 | 0.150 |
Why?
|
| Diagnostic Errors | 2 | 2014 | 318 | 0.150 |
Why?
|
| Intestinal Perforation | 1 | 2018 | 59 | 0.150 |
Why?
|
| Chronic Disease | 7 | 2013 | 1146 | 0.150 |
Why?
|
| Pseudomonas Infections | 5 | 1992 | 113 | 0.150 |
Why?
|
| Confidence Intervals | 2 | 2009 | 275 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2000 | 424 | 0.150 |
Why?
|
| Drug Industry | 2 | 1988 | 45 | 0.150 |
Why?
|
| HIV Protease Inhibitors | 1 | 1997 | 53 | 0.150 |
Why?
|
| Dirofilariasis | 1 | 1997 | 4 | 0.150 |
Why?
|
| Thermometers | 2 | 1987 | 11 | 0.150 |
Why?
|
| Dirofilaria immitis | 1 | 1997 | 5 | 0.150 |
Why?
|
| Zoonoses | 1 | 2017 | 43 | 0.140 |
Why?
|
| Diagnosis, Differential | 8 | 2009 | 1871 | 0.140 |
Why?
|
| Klebsiella Infections | 1 | 1997 | 51 | 0.140 |
Why?
|
| Low Back Pain | 1 | 1997 | 33 | 0.140 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 1997 | 23 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 654 | 0.140 |
Why?
|
| Symptom Flare Up | 1 | 2016 | 23 | 0.140 |
Why?
|
| Serogroup | 1 | 2016 | 49 | 0.140 |
Why?
|
| Cohort Studies | 5 | 2018 | 4640 | 0.140 |
Why?
|
| Molecular Mimicry | 1 | 1996 | 24 | 0.140 |
Why?
|
| Protective Factors | 1 | 2016 | 82 | 0.140 |
Why?
|
| Legionella | 1 | 2016 | 8 | 0.140 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 4284 | 0.130 |
Why?
|
| Pneumocystis carinii | 1 | 2016 | 10 | 0.130 |
Why?
|
| Lactams | 4 | 2000 | 14 | 0.130 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 1396 | 0.130 |
Why?
|
| Pain | 2 | 1998 | 450 | 0.130 |
Why?
|
| Syphilis, Congenital | 2 | 1996 | 28 | 0.130 |
Why?
|
| Biomarkers | 2 | 2020 | 2926 | 0.130 |
Why?
|
| Heart Failure | 3 | 2018 | 2122 | 0.130 |
Why?
|
| Dissent and Disputes | 1 | 2016 | 31 | 0.130 |
Why?
|
| Methenamine | 4 | 1977 | 7 | 0.130 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 84 | 0.130 |
Why?
|
| Medical Records | 2 | 2007 | 189 | 0.130 |
Why?
|
| Immunity, Cellular | 11 | 1992 | 206 | 0.130 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1995 | 24 | 0.130 |
Why?
|
| Lymphocyte Activation | 6 | 1992 | 690 | 0.120 |
Why?
|
| Clindamycin | 3 | 2006 | 40 | 0.120 |
Why?
|
| Whooping Cough | 1 | 1995 | 58 | 0.120 |
Why?
|
| beta-Lactams | 4 | 2019 | 50 | 0.120 |
Why?
|
| Advisory Committees | 1 | 2016 | 147 | 0.120 |
Why?
|
| Treatment Failure | 2 | 2007 | 332 | 0.120 |
Why?
|
| Publishing | 1 | 2016 | 103 | 0.120 |
Why?
|
| Colloids | 1 | 1994 | 16 | 0.120 |
Why?
|
| Clarithromycin | 1 | 1995 | 123 | 0.120 |
Why?
|
| Polyesters | 1 | 1994 | 39 | 0.120 |
Why?
|
| Leukocyte Count | 6 | 2012 | 249 | 0.120 |
Why?
|
| Treponema | 4 | 1986 | 7 | 0.120 |
Why?
|
| Haemophilus influenzae type b | 1 | 2014 | 5 | 0.120 |
Why?
|
| B-Lymphocytes | 2 | 1996 | 519 | 0.120 |
Why?
|
| Nasal Cavity | 1 | 2014 | 47 | 0.120 |
Why?
|
| Disease Management | 1 | 2018 | 512 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 708 | 0.110 |
Why?
|
| Epidural Abscess | 1 | 2014 | 9 | 0.110 |
Why?
|
| Influenza Vaccines | 2 | 2019 | 467 | 0.110 |
Why?
|
| Radiography | 6 | 1998 | 798 | 0.110 |
Why?
|
| Heart Transplantation | 1 | 2000 | 856 | 0.110 |
Why?
|
| Asia | 2 | 2004 | 105 | 0.110 |
Why?
|
| Myocardium | 1 | 2019 | 985 | 0.110 |
Why?
|
| Infant | 9 | 2014 | 12322 | 0.110 |
Why?
|
| DNA Transposable Elements | 2 | 1993 | 179 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 157 | 0.110 |
Why?
|
| Daptomycin | 2 | 2012 | 13 | 0.110 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2013 | 6 | 0.110 |
Why?
|
| Child | 10 | 2017 | 24081 | 0.110 |
Why?
|
| Scedosporium | 1 | 2013 | 7 | 0.110 |
Why?
|
| Antibodies, Viral | 3 | 2016 | 1130 | 0.110 |
Why?
|
| Syndrome | 1 | 2016 | 1118 | 0.110 |
Why?
|
| Radiography, Abdominal | 1 | 2013 | 47 | 0.110 |
Why?
|
| Administration, Oral | 4 | 2020 | 668 | 0.110 |
Why?
|
| Empyema, Subdural | 1 | 1992 | 9 | 0.110 |
Why?
|
| Aging | 2 | 1999 | 1160 | 0.110 |
Why?
|
| Pelvis | 1 | 2013 | 64 | 0.110 |
Why?
|
| Culture Media | 4 | 2010 | 183 | 0.100 |
Why?
|
| beta-Lactamases | 3 | 2011 | 195 | 0.100 |
Why?
|
| Mortality | 2 | 2012 | 221 | 0.100 |
Why?
|
| Microbiological Techniques | 1 | 2012 | 33 | 0.100 |
Why?
|
| Pyomyositis | 1 | 2012 | 3 | 0.100 |
Why?
|
| Abdomen | 3 | 2001 | 126 | 0.100 |
Why?
|
| Listeria monocytogenes | 8 | 1977 | 30 | 0.100 |
Why?
|
| Autoantibodies | 2 | 1992 | 421 | 0.100 |
Why?
|
| Postoperative Complications | 4 | 2005 | 2871 | 0.100 |
Why?
|
| ROC Curve | 1 | 2014 | 551 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 2 | 2012 | 143 | 0.100 |
Why?
|
| Dialysis | 1 | 2012 | 20 | 0.100 |
Why?
|
| Pulmonary Alveoli | 3 | 1990 | 140 | 0.100 |
Why?
|
| Altitude | 1 | 2012 | 21 | 0.100 |
Why?
|
| Oligopeptides | 1 | 1992 | 119 | 0.100 |
Why?
|
| Mycobacterium Infections | 3 | 2003 | 31 | 0.100 |
Why?
|
| Malaria, Vivax | 1 | 1991 | 8 | 0.100 |
Why?
|
| Hantavirus Pulmonary Syndrome | 1 | 2011 | 1 | 0.100 |
Why?
|
| Seoul virus | 1 | 2011 | 1 | 0.100 |
Why?
|
| Empyema | 4 | 1992 | 23 | 0.100 |
Why?
|
| Mycobacterium bovis | 3 | 2003 | 35 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 3072 | 0.100 |
Why?
|
| Treponemal Infections | 2 | 1986 | 3 | 0.100 |
Why?
|
| Catheters | 1 | 2012 | 84 | 0.100 |
Why?
|
| Genome, Bacterial | 1 | 2012 | 184 | 0.100 |
Why?
|
| Urea | 2 | 2012 | 210 | 0.100 |
Why?
|
| Diabetes Mellitus | 2 | 2010 | 843 | 0.100 |
Why?
|
| Skin Ulcer | 1 | 2011 | 32 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2014 | 446 | 0.090 |
Why?
|
| Hemolysis | 2 | 2009 | 103 | 0.090 |
Why?
|
| Respiratory Paralysis | 1 | 2010 | 7 | 0.090 |
Why?
|
| Prostheses and Implants | 1 | 2012 | 151 | 0.090 |
Why?
|
| Sex Distribution | 2 | 2013 | 283 | 0.090 |
Why?
|
| Tertiary Prevention | 1 | 2010 | 1 | 0.090 |
Why?
|
| Molecular Sequence Data | 7 | 2006 | 3870 | 0.090 |
Why?
|
| Radioimmunoassay | 5 | 1990 | 111 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 80 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 863 | 0.090 |
Why?
|
| Methicillin | 1 | 2010 | 43 | 0.090 |
Why?
|
| Age Distribution | 2 | 2013 | 399 | 0.090 |
Why?
|
| Odds Ratio | 2 | 2016 | 1226 | 0.090 |
Why?
|
| Nursing Homes | 3 | 2016 | 95 | 0.090 |
Why?
|
| BCG Vaccine | 3 | 2003 | 114 | 0.090 |
Why?
|
| Pharynx | 4 | 1997 | 63 | 0.090 |
Why?
|
| Staining and Labeling | 5 | 2004 | 187 | 0.090 |
Why?
|
| Kidney Diseases | 3 | 2013 | 471 | 0.090 |
Why?
|
| Prevalence | 3 | 2012 | 2371 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2011 | 299 | 0.090 |
Why?
|
| Survival Analysis | 4 | 2018 | 1461 | 0.090 |
Why?
|
| Creatinine | 2 | 2012 | 376 | 0.090 |
Why?
|
| Vibrio | 3 | 1986 | 11 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3289 | 0.090 |
Why?
|
| Blood Culture | 2 | 2021 | 29 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2014 | 13802 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2012 | 1004 | 0.090 |
Why?
|
| Dysentery, Bacillary | 1 | 1990 | 9 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2011 | 178 | 0.090 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 211 | 0.090 |
Why?
|
| Survivors | 1 | 2013 | 344 | 0.090 |
Why?
|
| Shigella flexneri | 1 | 1990 | 13 | 0.090 |
Why?
|
| Diarrhea | 3 | 2009 | 318 | 0.090 |
Why?
|
| HIV-1 | 3 | 2002 | 471 | 0.090 |
Why?
|
| Aspirin | 1 | 2011 | 220 | 0.080 |
Why?
|
| Glomerulonephritis | 1 | 1990 | 76 | 0.080 |
Why?
|
| Dyspnea | 1 | 2010 | 148 | 0.080 |
Why?
|
| Neisseria | 3 | 1986 | 3 | 0.080 |
Why?
|
| Wound Infection | 2 | 1988 | 51 | 0.080 |
Why?
|
| Fatal Outcome | 2 | 2002 | 354 | 0.080 |
Why?
|
| Placebos | 1 | 2010 | 239 | 0.080 |
Why?
|
| Antidiarrheals | 1 | 2009 | 17 | 0.080 |
Why?
|
| Skin Diseases | 2 | 1989 | 121 | 0.080 |
Why?
|
| Length of Stay | 2 | 2014 | 1251 | 0.080 |
Why?
|
| Q Fever | 1 | 1988 | 1 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 5 | 2001 | 67 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2014 | 480 | 0.080 |
Why?
|
| Bronchoscopy | 2 | 2008 | 155 | 0.080 |
Why?
|
| Amino Acid Sequence | 5 | 1998 | 2677 | 0.080 |
Why?
|
| Molecular Weight | 5 | 1996 | 393 | 0.080 |
Why?
|
| Gangrene | 4 | 2018 | 25 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 489 | 0.080 |
Why?
|
| Blister | 1 | 2008 | 19 | 0.080 |
Why?
|
| Endotoxins | 2 | 1979 | 51 | 0.080 |
Why?
|
| Diphtheria Toxoid | 1 | 1988 | 9 | 0.080 |
Why?
|
| Salmonella typhimurium | 3 | 1979 | 41 | 0.080 |
Why?
|
| Soil Microbiology | 1 | 1988 | 12 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2008 | 164 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 68 | 0.080 |
Why?
|
| Epitope Mapping | 3 | 1998 | 78 | 0.080 |
Why?
|
| Immunity | 3 | 1998 | 183 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2012 | 457 | 0.080 |
Why?
|
| Cell Separation | 1 | 1988 | 238 | 0.080 |
Why?
|
| Mucormycosis | 1 | 1988 | 26 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2011 | 359 | 0.070 |
Why?
|
| Brucella abortus | 2 | 1985 | 3 | 0.070 |
Why?
|
| Brucella | 2 | 1985 | 4 | 0.070 |
Why?
|
| Immunoglobulin A | 2 | 1988 | 200 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2014 | 8103 | 0.070 |
Why?
|
| Lung Diseases, Parasitic | 2 | 1985 | 14 | 0.070 |
Why?
|
| Spleen | 8 | 1979 | 286 | 0.070 |
Why?
|
| Neoplasms | 2 | 2021 | 2753 | 0.070 |
Why?
|
| Congresses as Topic | 1 | 1988 | 164 | 0.070 |
Why?
|
| Consensus | 2 | 2020 | 605 | 0.070 |
Why?
|
| Binding Sites | 4 | 2006 | 1292 | 0.070 |
Why?
|
| Parasitic Diseases | 1 | 2007 | 58 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1574 | 0.070 |
Why?
|
| Foodborne Diseases | 2 | 2004 | 11 | 0.070 |
Why?
|
| Coccidioidomycosis | 1 | 1986 | 13 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 184 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 1243 | 0.070 |
Why?
|
| Probability | 1 | 2007 | 319 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 164 | 0.070 |
Why?
|
| Thoracic Neoplasms | 1 | 1986 | 38 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 739 | 0.070 |
Why?
|
| Ampicillin | 3 | 2001 | 58 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2009 | 332 | 0.070 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2006 | 14 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2010 | 642 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1279 | 0.070 |
Why?
|
| Rifampin | 3 | 2004 | 144 | 0.070 |
Why?
|
| Outpatients | 2 | 2012 | 252 | 0.070 |
Why?
|
| Caliciviridae Infections | 1 | 2009 | 314 | 0.070 |
Why?
|
| Cerebrospinal Fluid | 2 | 1998 | 92 | 0.060 |
Why?
|
| Vancomycin Resistance | 1 | 2005 | 20 | 0.060 |
Why?
|
| Enterobacteriaceae | 3 | 1981 | 34 | 0.060 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2008 | 251 | 0.060 |
Why?
|
| Pleurisy | 1 | 1985 | 6 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2006 | 111 | 0.060 |
Why?
|
| Chickenpox | 1 | 1985 | 20 | 0.060 |
Why?
|
| Smoking | 3 | 1997 | 1027 | 0.060 |
Why?
|
| Norovirus | 1 | 2009 | 302 | 0.060 |
Why?
|
| Foreign Bodies | 1 | 1986 | 102 | 0.060 |
Why?
|
| Liver Abscess, Amebic | 1 | 1985 | 3 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2006 | 210 | 0.060 |
Why?
|
| Remission Induction | 1 | 2006 | 301 | 0.060 |
Why?
|
| Pedigree | 2 | 2000 | 1576 | 0.060 |
Why?
|
| Glycosaminoglycans | 2 | 1982 | 36 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2009 | 1568 | 0.060 |
Why?
|
| Orthomyxoviridae | 2 | 2003 | 52 | 0.060 |
Why?
|
| Pleural Diseases | 1 | 1985 | 28 | 0.060 |
Why?
|
| Protozoan Infections | 1 | 2004 | 12 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 196 | 0.060 |
Why?
|
| Cross Reactions | 3 | 1996 | 194 | 0.060 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1985 | 76 | 0.060 |
Why?
|
| Cell Survival | 1 | 2007 | 818 | 0.060 |
Why?
|
| Microscopy, Electron | 6 | 1990 | 402 | 0.060 |
Why?
|
| Immunization | 3 | 1996 | 303 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2010 | 1457 | 0.060 |
Why?
|
| Urease | 5 | 1976 | 73 | 0.060 |
Why?
|
| Neisseria meningitidis | 2 | 2003 | 19 | 0.060 |
Why?
|
| Tetracycline | 2 | 1975 | 78 | 0.060 |
Why?
|
| Listeriosis | 7 | 1979 | 18 | 0.060 |
Why?
|
| Penicillin G Procaine | 1 | 2004 | 2 | 0.060 |
Why?
|
| Histoplasmosis | 2 | 1989 | 45 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2016 | 404 | 0.060 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2005 | 85 | 0.060 |
Why?
|
| Bronchi | 2 | 1984 | 99 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2006 | 396 | 0.060 |
Why?
|
| Proteus | 2 | 1974 | 7 | 0.060 |
Why?
|
| Epitopes | 1 | 1986 | 427 | 0.060 |
Why?
|
| Immune Sera | 4 | 1990 | 98 | 0.060 |
Why?
|
| Immunity, Active | 2 | 2000 | 7 | 0.060 |
Why?
|
| Mice, Inbred Strains | 5 | 1990 | 317 | 0.060 |
Why?
|
| Colon | 1 | 1986 | 347 | 0.060 |
Why?
|
| False Positive Reactions | 2 | 1994 | 142 | 0.060 |
Why?
|
| Paleontology | 1 | 2003 | 1 | 0.060 |
Why?
|
| Escherichia coli Infections | 1 | 2006 | 190 | 0.060 |
Why?
|
| Mongolia | 1 | 2003 | 6 | 0.060 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2003 | 19 | 0.060 |
Why?
|
| Tracheitis | 1 | 1983 | 14 | 0.060 |
Why?
|
| Mutation | 4 | 2006 | 5766 | 0.060 |
Why?
|
| Phosphorylcholine | 2 | 1998 | 26 | 0.060 |
Why?
|
| Meningitis | 3 | 1988 | 99 | 0.060 |
Why?
|
| Yersinia Infections | 1 | 1983 | 4 | 0.050 |
Why?
|
| Streptomycin | 2 | 1993 | 18 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2793 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2003 | 118 | 0.050 |
Why?
|
| Dysgammaglobulinemia | 1 | 1983 | 3 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2022 | 977 | 0.050 |
Why?
|
| Lymphocytes | 6 | 1987 | 416 | 0.050 |
Why?
|
| Erysipelas | 2 | 1980 | 2 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2001 | 208 | 0.050 |
Why?
|
| Rhinovirus | 1 | 2003 | 62 | 0.050 |
Why?
|
| Antigens, Human Platelet | 1 | 2002 | 6 | 0.050 |
Why?
|
| Pressure Ulcer | 3 | 1994 | 76 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2007 | 875 | 0.050 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2002 | 39 | 0.050 |
Why?
|
| Tetracycline Resistance | 2 | 1993 | 7 | 0.050 |
Why?
|
| Probiotics | 1 | 2005 | 209 | 0.050 |
Why?
|
| Hodgkin Disease | 1 | 1985 | 293 | 0.050 |
Why?
|
| Intestinal Fistula | 1 | 1982 | 28 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2008 | 658 | 0.050 |
Why?
|
| Concanavalin A | 1 | 1982 | 16 | 0.050 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2002 | 19 | 0.050 |
Why?
|
| Cefazolin | 1 | 1982 | 20 | 0.050 |
Why?
|
| Duodenal Diseases | 1 | 1982 | 34 | 0.050 |
Why?
|
| Alleles | 2 | 2000 | 1596 | 0.050 |
Why?
|
| Debridement | 2 | 2018 | 83 | 0.050 |
Why?
|
| Ascitic Fluid | 2 | 1979 | 31 | 0.050 |
Why?
|
| Biofilms | 1 | 2002 | 93 | 0.050 |
Why?
|
| Complement System Proteins | 4 | 1986 | 63 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1988 | 313 | 0.050 |
Why?
|
| Arthritis, Infectious | 2 | 1998 | 60 | 0.050 |
Why?
|
| Pericarditis | 2 | 1978 | 41 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 1997 | 3074 | 0.050 |
Why?
|
| DNA Fingerprinting | 2 | 1999 | 105 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2001 | 105 | 0.050 |
Why?
|
| Connective Tissue | 1 | 1980 | 20 | 0.050 |
Why?
|
| Genes, Bacterial | 2 | 2012 | 207 | 0.050 |
Why?
|
| Genetic Variation | 3 | 1993 | 1475 | 0.050 |
Why?
|
| Erythrocytes | 2 | 1979 | 207 | 0.050 |
Why?
|
| Sutures | 1 | 1981 | 67 | 0.050 |
Why?
|
| Mitogens | 2 | 1978 | 30 | 0.050 |
Why?
|
| In Vitro Techniques | 6 | 1988 | 971 | 0.040 |
Why?
|
| Adsorption | 2 | 1990 | 34 | 0.040 |
Why?
|
| Cefamandole | 1 | 1980 | 3 | 0.040 |
Why?
|
| Exotoxins | 2 | 2006 | 44 | 0.040 |
Why?
|
| Heterozygote | 1 | 2002 | 681 | 0.040 |
Why?
|
| Conjunctivitis, Bacterial | 1 | 1999 | 5 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1982 | 325 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 169 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2002 | 265 | 0.040 |
Why?
|
| Moraxellaceae Infections | 1 | 2019 | 1 | 0.040 |
Why?
|
| Chlamydophila Infections | 1 | 2019 | 3 | 0.040 |
Why?
|
| Gas Gangrene | 2 | 1990 | 6 | 0.040 |
Why?
|
| Brucellosis | 1 | 1979 | 17 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2003 | 638 | 0.040 |
Why?
|
| Legionellosis | 1 | 2019 | 4 | 0.040 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 1979 | 17 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2019 | 92 | 0.040 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2019 | 14 | 0.040 |
Why?
|
| Epidural Space | 2 | 1992 | 23 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2001 | 369 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 805 | 0.040 |
Why?
|
| Patient Admission | 1 | 2000 | 183 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2000 | 328 | 0.040 |
Why?
|
| Skin | 3 | 1980 | 503 | 0.040 |
Why?
|
| Confusion | 1 | 1998 | 16 | 0.040 |
Why?
|
| Foot Ulcer | 1 | 2018 | 18 | 0.040 |
Why?
|
| Immunocompetence | 1 | 1998 | 33 | 0.040 |
Why?
|
| Knee | 1 | 1998 | 15 | 0.040 |
Why?
|
| Meningitis, Fungal | 1 | 1998 | 4 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2003 | 456 | 0.040 |
Why?
|
| Kinetics | 4 | 2004 | 1317 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 482 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2000 | 708 | 0.040 |
Why?
|
| Homozygote | 1 | 2000 | 534 | 0.040 |
Why?
|
| Complement Activation | 3 | 1986 | 55 | 0.040 |
Why?
|
| Conjunctivitis | 1 | 1997 | 22 | 0.040 |
Why?
|
| Mannose | 1 | 1997 | 19 | 0.040 |
Why?
|
| Pyuria | 2 | 1993 | 6 | 0.040 |
Why?
|
| Hospitals | 2 | 2012 | 396 | 0.040 |
Why?
|
| Sex Factors | 2 | 2018 | 1231 | 0.040 |
Why?
|
| Fimbriae, Bacterial | 1 | 1997 | 41 | 0.040 |
Why?
|
| Bone and Bones | 3 | 1994 | 262 | 0.040 |
Why?
|
| Drug Synergism | 4 | 2004 | 233 | 0.040 |
Why?
|
| Respiratory System | 1 | 1998 | 96 | 0.040 |
Why?
|
| Syphilis, Latent | 2 | 1992 | 2 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 1997 | 61 | 0.040 |
Why?
|
| Meningitis, Bacterial | 1 | 1998 | 94 | 0.040 |
Why?
|
| Amphotericin B | 3 | 2013 | 90 | 0.040 |
Why?
|
| Jews | 1 | 1997 | 31 | 0.040 |
Why?
|
| Hernia, Hiatal | 1 | 1997 | 54 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 1997 | 108 | 0.030 |
Why?
|
| Immunoglobulins | 3 | 1983 | 173 | 0.030 |
Why?
|
| Genotype | 2 | 2000 | 2533 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 1997 | 148 | 0.030 |
Why?
|
| Amikacin | 2 | 1991 | 24 | 0.030 |
Why?
|
| Joint Diseases | 2 | 1994 | 33 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 1991 | 297 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2019 | 376 | 0.030 |
Why?
|
| Cloning, Molecular | 3 | 1995 | 887 | 0.030 |
Why?
|
| Proteus Infections | 2 | 1976 | 8 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2002 | 568 | 0.030 |
Why?
|
| Ecthyma | 2 | 1989 | 2 | 0.030 |
Why?
|
| Ofloxacin | 1 | 1995 | 32 | 0.030 |
Why?
|
| Pleura | 1 | 1995 | 24 | 0.030 |
Why?
|
| Hemolytic Plaque Technique | 3 | 1980 | 7 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 368 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1985 | 1613 | 0.030 |
Why?
|
| Brain Abscess | 2 | 2013 | 57 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2006 | 91 | 0.030 |
Why?
|
| Cattle | 1 | 1996 | 556 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1986 | 70 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1976 | 425 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 1986 | 105 | 0.030 |
Why?
|
| Collagen | 1 | 1996 | 312 | 0.030 |
Why?
|
| Occlusive Dressings | 1 | 1994 | 6 | 0.030 |
Why?
|
| Luminescent Measurements | 3 | 1988 | 57 | 0.030 |
Why?
|
| Prisons | 1 | 1994 | 11 | 0.030 |
Why?
|
| Formaldehyde | 1 | 1974 | 31 | 0.030 |
Why?
|
| Opossums | 1 | 1974 | 12 | 0.030 |
Why?
|
| Minocycline | 1 | 1974 | 36 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 92 | 0.030 |
Why?
|
| Military Personnel | 1 | 1997 | 205 | 0.030 |
Why?
|
| Lumbar Vertebrae | 2 | 1987 | 106 | 0.030 |
Why?
|
| Air Pollution, Indoor | 1 | 1994 | 30 | 0.030 |
Why?
|
| Staphylococcal Skin Infections | 1 | 1994 | 37 | 0.030 |
Why?
|
| Air Pollutants | 1 | 1996 | 100 | 0.030 |
Why?
|
| Seasons | 1 | 1996 | 299 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 1996 | 218 | 0.030 |
Why?
|
| Enterococcus faecalis | 1 | 1974 | 43 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 1068 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 1993 | 28 | 0.030 |
Why?
|
| Sheep | 2 | 1988 | 211 | 0.030 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 1997 | 295 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 1994 | 109 | 0.030 |
Why?
|
| Asymptomatic Infections | 1 | 2013 | 33 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1993 | 114 | 0.030 |
Why?
|
| Voriconazole | 1 | 2013 | 35 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 202 | 0.030 |
Why?
|
| Africa, Western | 1 | 2012 | 12 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 293 | 0.030 |
Why?
|
| Prophages | 1 | 2012 | 6 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2013 | 106 | 0.030 |
Why?
|
| Purpura | 2 | 1992 | 24 | 0.030 |
Why?
|
| Psychosurgery | 1 | 2013 | 27 | 0.030 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2012 | 12 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2012 | 29 | 0.030 |
Why?
|
| Streptococcal Vaccines | 1 | 2012 | 17 | 0.030 |
Why?
|
| Yeasts | 1 | 2012 | 42 | 0.030 |
Why?
|
| Medicine | 2 | 1965 | 97 | 0.030 |
Why?
|
| Nitrites | 1 | 2012 | 45 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2003 | 418 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1992 | 66 | 0.030 |
Why?
|
| Chromosomes, Bacterial | 1 | 2012 | 64 | 0.030 |
Why?
|
| Peptidoglycan | 2 | 1983 | 16 | 0.030 |
Why?
|
| Otitis Externa | 1 | 1992 | 5 | 0.030 |
Why?
|
| Forecasting | 1 | 2014 | 354 | 0.030 |
Why?
|
| El Salvador | 1 | 1991 | 4 | 0.030 |
Why?
|
| Triazoles | 1 | 2013 | 138 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2003 | 570 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2012 | 292 | 0.020 |
Why?
|
| Antimalarials | 1 | 1991 | 37 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2013 | 99 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1992 | 141 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1993 | 526 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 1991 | 81 | 0.020 |
Why?
|
| Methylmethacrylates | 1 | 1991 | 13 | 0.020 |
Why?
|
| Skin Diseases, Infectious | 2 | 1988 | 24 | 0.020 |
Why?
|
| Bone Cements | 1 | 1991 | 11 | 0.020 |
Why?
|
| Trimethoprim Resistance | 1 | 1991 | 1 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2012 | 170 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 259 | 0.020 |
Why?
|
| Boric Acids | 1 | 1970 | 1 | 0.020 |
Why?
|
| Dermatitis, Exfoliative | 1 | 1970 | 4 | 0.020 |
Why?
|
| Monocytes | 1 | 1993 | 359 | 0.020 |
Why?
|
| Phylogeny | 2 | 2006 | 681 | 0.020 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 1970 | 14 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 267 | 0.020 |
Why?
|
| Pleural Effusion | 3 | 1992 | 99 | 0.020 |
Why?
|
| History, 18th Century | 2 | 1987 | 69 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 1990 | 66 | 0.020 |
Why?
|
| Dimercaprol | 1 | 1990 | 4 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 1990 | 68 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2013 | 293 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 1993 | 477 | 0.020 |
Why?
|
| Clostridium | 1 | 1990 | 16 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2012 | 171 | 0.020 |
Why?
|
| Immunization, Passive | 4 | 1999 | 117 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2013 | 375 | 0.020 |
Why?
|
| Demography | 1 | 2010 | 238 | 0.020 |
Why?
|
| Scarlet Fever | 1 | 1989 | 2 | 0.020 |
Why?
|
| Immune Complex Diseases | 1 | 1989 | 7 | 0.020 |
Why?
|
| Paralysis | 1 | 1989 | 36 | 0.020 |
Why?
|
| Ketoconazole | 1 | 1989 | 11 | 0.020 |
Why?
|
| Hindlimb | 1 | 1989 | 76 | 0.020 |
Why?
|
| Surgical Wound Infection | 3 | 1981 | 257 | 0.020 |
Why?
|
| Coxiella | 1 | 1988 | 1 | 0.020 |
Why?
|
| Lung Diseases, Fungal | 1 | 1989 | 34 | 0.020 |
Why?
|
| Joint Prosthesis | 1 | 1989 | 12 | 0.020 |
Why?
|
| Sheep Diseases | 1 | 1988 | 7 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2009 | 95 | 0.020 |
Why?
|
| Animal Diseases | 1 | 1988 | 6 | 0.020 |
Why?
|
| Goats | 1 | 1988 | 56 | 0.020 |
Why?
|
| Muscles | 1 | 1989 | 289 | 0.020 |
Why?
|
| Prevotella melaninogenica | 1 | 2008 | 2 | 0.020 |
Why?
|
| Hemolysin Proteins | 2 | 1979 | 29 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 857 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1970 | 174 | 0.020 |
Why?
|
| Rhizopus | 1 | 1988 | 10 | 0.020 |
Why?
|
| Pulmonary Medicine | 1 | 2008 | 25 | 0.020 |
Why?
|
| Glycoproteins | 2 | 1996 | 371 | 0.020 |
Why?
|
| Temperature | 2 | 1996 | 304 | 0.020 |
Why?
|
| Chancre | 2 | 1977 | 2 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 487 | 0.020 |
Why?
|
| Rats | 4 | 1998 | 3655 | 0.020 |
Why?
|
| Candidiasis | 1 | 1989 | 129 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2006 | 1758 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 1978 | 254 | 0.020 |
Why?
|
| Aspergillosis | 1 | 1987 | 42 | 0.020 |
Why?
|
| Body Temperature | 1 | 1987 | 103 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 192 | 0.020 |
Why?
|
| Heroin Dependence | 1 | 1987 | 56 | 0.020 |
Why?
|
| Social Medicine | 1 | 1987 | 1 | 0.020 |
Why?
|
| Distemper Virus, Canine | 1 | 1986 | 3 | 0.020 |
Why?
|
| Random Allocation | 1 | 1988 | 416 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 1987 | 65 | 0.020 |
Why?
|
| Osteitis Deformans | 1 | 1986 | 7 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 2 | 1978 | 74 | 0.020 |
Why?
|
| France | 1 | 1987 | 76 | 0.020 |
Why?
|
| Coccidioides | 1 | 1986 | 2 | 0.020 |
Why?
|
| Antibodies | 1 | 2008 | 383 | 0.020 |
Why?
|
| Base Sequence | 3 | 1998 | 3115 | 0.020 |
Why?
|
| Leukocidins | 1 | 2006 | 37 | 0.020 |
Why?
|
| Lectins | 3 | 1975 | 49 | 0.020 |
Why?
|
| Nafcillin | 2 | 1986 | 14 | 0.020 |
Why?
|
| Sternum | 1 | 1986 | 53 | 0.020 |
Why?
|
| Complement Pathway, Classical | 1 | 1986 | 4 | 0.020 |
Why?
|
| Complement Activating Enzymes | 1 | 1986 | 9 | 0.020 |
Why?
|
| Paper | 1 | 1986 | 6 | 0.020 |
Why?
|
| Collodion | 1 | 1986 | 8 | 0.020 |
Why?
|
| Hot Temperature | 2 | 1985 | 135 | 0.020 |
Why?
|
| Complement C1q | 1 | 1986 | 22 | 0.020 |
Why?
|
| Complement Pathway, Alternative | 1 | 1986 | 15 | 0.020 |
Why?
|
| Turkey | 1 | 2006 | 57 | 0.020 |
Why?
|
| Proteus mirabilis | 2 | 1976 | 12 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1988 | 509 | 0.020 |
Why?
|
| Urinary Calculi | 2 | 1976 | 18 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 1986 | 43 | 0.020 |
Why?
|
| Lethal Dose 50 | 3 | 1984 | 17 | 0.020 |
Why?
|
| History | 1 | 1965 | 4 | 0.020 |
Why?
|
| Flagellin | 1 | 1985 | 16 | 0.020 |
Why?
|
| Epidemiology | 1 | 1965 | 9 | 0.020 |
Why?
|
| Smallpox | 1 | 1965 | 10 | 0.020 |
Why?
|
| Acyclovir | 1 | 1985 | 45 | 0.020 |
Why?
|
| Vacuoles | 1 | 1985 | 24 | 0.020 |
Why?
|
| Thymidine | 2 | 1975 | 58 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 1986 | 138 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2002 | 470 | 0.020 |
Why?
|
| Bronchial Diseases | 1 | 1985 | 11 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 1985 | 47 | 0.020 |
Why?
|
| Peptides | 2 | 1991 | 799 | 0.020 |
Why?
|
| Smallpox Vaccine | 1 | 1965 | 36 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1993 | 1526 | 0.020 |
Why?
|
| Epidemics | 1 | 1965 | 52 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 1988 | 293 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1370 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1986 | 218 | 0.010 |
Why?
|
| Reagins | 1 | 2004 | 3 | 0.010 |
Why?
|
| Alcoholism | 1 | 1986 | 229 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 447 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1985 | 291 | 0.010 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2003 | 11 | 0.010 |
Why?
|
| Legionnaires' Disease | 1 | 2003 | 6 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1983 | 104 | 0.010 |
Why?
|
| Bioterrorism | 1 | 2003 | 11 | 0.010 |
Why?
|
| Liver | 5 | 1979 | 1853 | 0.010 |
Why?
|
| Cefotaxime | 1 | 2003 | 35 | 0.010 |
Why?
|
| Kidney | 3 | 1977 | 1328 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2004 | 193 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2581 | 0.010 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2003 | 36 | 0.010 |
Why?
|
| Escherichia coli | 3 | 1980 | 979 | 0.010 |
Why?
|
| Yersinia enterocolitica | 1 | 1983 | 1 | 0.010 |
Why?
|
| Carbon Isotopes | 3 | 1972 | 272 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1983 | 117 | 0.010 |
Why?
|
| Radionuclide Imaging | 2 | 1983 | 152 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2003 | 103 | 0.010 |
Why?
|
| Jurisprudence | 1 | 1962 | 14 | 0.010 |
Why?
|
| Injections, Intradermal | 1 | 1983 | 31 | 0.010 |
Why?
|
| Pregnancy | 1 | 1996 | 7082 | 0.010 |
Why?
|
| Proviruses | 1 | 2002 | 18 | 0.010 |
Why?
|
| Licensure | 1 | 1962 | 15 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2007 | 670 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2002 | 25 | 0.010 |
Why?
|
| Licensure, Medical | 1 | 1962 | 24 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 244 | 0.010 |
Why?
|
| Hospital Units | 1 | 1982 | 17 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 1982 | 24 | 0.010 |
Why?
|
| Quadriplegia | 1 | 1982 | 33 | 0.010 |
Why?
|
| Hepatitis | 1 | 2003 | 65 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 669 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2002 | 69 | 0.010 |
Why?
|
| HIV | 1 | 2003 | 179 | 0.010 |
Why?
|
| Methyldopa | 1 | 1982 | 4 | 0.010 |
Why?
|
| Hydralazine | 1 | 1982 | 8 | 0.010 |
Why?
|
| Antibody-Producing Cells | 2 | 1979 | 8 | 0.010 |
Why?
|
| Nitrofurantoin | 1 | 1982 | 9 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1988 | 1025 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 2002 | 115 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 755 | 0.010 |
Why?
|
| Phenytoin | 1 | 1982 | 64 | 0.010 |
Why?
|
| Staphylococcal Protein A | 1 | 1981 | 7 | 0.010 |
Why?
|
| Teichoic Acids | 1 | 1981 | 13 | 0.010 |
Why?
|
| Peritoneal Diseases | 1 | 2001 | 9 | 0.010 |
Why?
|
| Cell Wall | 1 | 1981 | 34 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1982 | 168 | 0.010 |
Why?
|
| Genes, rRNA | 1 | 2001 | 18 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 194 | 0.010 |
Why?
|
| Isoniazid | 1 | 1982 | 70 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2003 | 190 | 0.010 |
Why?
|
| Leucomycins | 1 | 1981 | 2 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2002 | 493 | 0.010 |
Why?
|
| Campylobacter fetus | 1 | 1980 | 3 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1982 | 252 | 0.010 |
Why?
|
| Vaccines, Attenuated | 2 | 1980 | 171 | 0.010 |
Why?
|
| Allopurinol | 1 | 1982 | 69 | 0.010 |
Why?
|
| Pasteurella Infections | 1 | 1980 | 8 | 0.010 |
Why?
|
| Campylobacter Infections | 1 | 1980 | 34 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 1980 | 22 | 0.010 |
Why?
|
| Pronase | 1 | 1980 | 4 | 0.010 |
Why?
|
| Fasciitis | 1 | 1980 | 20 | 0.010 |
Why?
|
| Viral Load | 1 | 2002 | 381 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1982 | 96 | 0.010 |
Why?
|
| Trypsin | 1 | 1980 | 96 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1984 | 1681 | 0.010 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1980 | 26 | 0.010 |
Why?
|
| Strongyloidiasis | 1 | 1980 | 43 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1985 | 648 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 259 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2002 | 541 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1982 | 220 | 0.010 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1980 | 37 | 0.010 |
Why?
|
| Massachusetts | 2 | 1973 | 124 | 0.010 |
Why?
|
| Enterobacteriaceae Infections | 1 | 1980 | 55 | 0.010 |
Why?
|
| Kanamycin | 1 | 1979 | 6 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2004 | 1361 | 0.010 |
Why?
|
| Animals, Laboratory | 1 | 1979 | 11 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1999 | 41 | 0.010 |
Why?
|
| Parotitis | 1 | 1979 | 5 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1980 | 148 | 0.010 |
Why?
|
| Nocardia Infections | 1 | 1979 | 15 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 1981 | 170 | 0.010 |
Why?
|
| Colistin | 2 | 1980 | 30 | 0.010 |
Why?
|
| Heart Atria | 1 | 1981 | 308 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1990 | 337 | 0.010 |
Why?
|
| Antigens | 1 | 1979 | 161 | 0.010 |
Why?
|
| Candida | 2 | 1979 | 75 | 0.010 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1979 | 76 | 0.010 |
Why?
|
| Histoplasma | 1 | 1978 | 28 | 0.010 |
Why?
|
| Aorta | 1 | 1982 | 519 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1986 | 785 | 0.010 |
Why?
|
| Serratia marcescens | 1 | 1978 | 10 | 0.010 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1978 | 12 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 1980 | 191 | 0.010 |
Why?
|
| Lipid A | 1 | 1978 | 22 | 0.010 |
Why?
|
| Mycoses | 1 | 1979 | 116 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 1978 | 23 | 0.010 |
Why?
|
| Tonsillitis | 1 | 1978 | 13 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1978 | 64 | 0.010 |
Why?
|
| Biopsy | 3 | 1994 | 1244 | 0.010 |
Why?
|
| Eye | 1 | 1999 | 227 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1998 | 98 | 0.010 |
Why?
|
| Furunculosis | 1 | 1977 | 4 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2003 | 542 | 0.010 |
Why?
|
| Impetigo | 1 | 1977 | 5 | 0.010 |
Why?
|
| Coagulase | 1 | 1977 | 21 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1977 | 26 | 0.010 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1998 | 79 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1978 | 58 | 0.010 |
Why?
|
| Mannitol | 1 | 1977 | 48 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1977 | 78 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1979 | 268 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1977 | 126 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1979 | 258 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1979 | 213 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1975 | 469 | 0.010 |
Why?
|
| Nocardia | 1 | 1977 | 9 | 0.010 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1978 | 92 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1979 | 378 | 0.010 |
Why?
|
| Propionibacterium acnes | 1 | 1977 | 12 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1982 | 937 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 1979 | 179 | 0.010 |
Why?
|
| Brain Diseases | 1 | 1979 | 296 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1977 | 156 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1999 | 381 | 0.010 |
Why?
|
| Cell Division | 1 | 1978 | 796 | 0.010 |
Why?
|
| Leukemia | 1 | 1979 | 378 | 0.010 |
Why?
|
| Sulfur Dioxide | 1 | 1996 | 4 | 0.010 |
Why?
|
| Drainage | 1 | 1978 | 250 | 0.010 |
Why?
|
| Echocardiography | 1 | 1981 | 1065 | 0.010 |
Why?
|
| Carbon Dioxide | 2 | 1994 | 274 | 0.010 |
Why?
|
| Specimen Handling | 1 | 1976 | 137 | 0.010 |
Why?
|
| Ammonia | 1 | 1976 | 68 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 82 | 0.010 |
Why?
|
| Arthrodermataceae | 1 | 1975 | 1 | 0.010 |
Why?
|
| Mumps Vaccine | 1 | 1975 | 1 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 217 | 0.010 |
Why?
|
| Carbenicillin | 1 | 1975 | 2 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 474 | 0.010 |
Why?
|
| Antigens, Fungal | 1 | 1975 | 34 | 0.010 |
Why?
|
| Cholesterol | 2 | 1990 | 517 | 0.010 |
Why?
|
| Tritium | 1 | 1975 | 177 | 0.010 |
Why?
|
| Chemistry | 1 | 1975 | 61 | 0.010 |
Why?
|
| Leptospirosis | 1 | 1975 | 5 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1975 | 85 | 0.010 |
Why?
|
| Homosexuality | 1 | 1975 | 18 | 0.010 |
Why?
|
| Proctitis | 1 | 1975 | 6 | 0.010 |
Why?
|
| Cephalothin | 1 | 1974 | 6 | 0.010 |
Why?
|
| Melena | 1 | 1974 | 5 | 0.010 |
Why?
|
| Seawater | 1 | 1974 | 13 | 0.010 |
Why?
|
| Hematemesis | 1 | 1974 | 6 | 0.010 |
Why?
|
| Water Microbiology | 1 | 1974 | 23 | 0.010 |
Why?
|
| Ventilation | 1 | 1994 | 5 | 0.010 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1975 | 33 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1975 | 101 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1996 | 269 | 0.010 |
Why?
|
| Crowding | 1 | 1994 | 9 | 0.010 |
Why?
|
| Contraindications | 1 | 1994 | 77 | 0.010 |
Why?
|
| Acetamides | 1 | 1975 | 49 | 0.010 |
Why?
|
| Biological Assay | 1 | 1974 | 101 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1975 | 171 | 0.010 |
Why?
|
| Dogs | 1 | 1975 | 775 | 0.010 |
Why?
|
| Oxacillin | 1 | 1993 | 6 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 1973 | 54 | 0.010 |
Why?
|
| Mice, Hairless | 1 | 1993 | 30 | 0.010 |
Why?
|
| Streptokinase | 1 | 1993 | 20 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 142 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 4208 | 0.010 |
Why?
|
| Rhinoscleroma | 1 | 1992 | 4 | 0.010 |
Why?
|
| Tetracyclines | 1 | 1992 | 13 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1975 | 313 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 1711 | 0.010 |
Why?
|
| Lactates | 1 | 1972 | 93 | 0.010 |
Why?
|
| North America | 1 | 1993 | 233 | 0.010 |
Why?
|
| Peritoneum | 1 | 1972 | 36 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1972 | 34 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1972 | 170 | 0.010 |
Why?
|
| DNA | 1 | 1978 | 1608 | 0.010 |
Why?
|
| Mediastinitis | 1 | 1992 | 13 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1975 | 581 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1993 | 153 | 0.010 |
Why?
|
| Europe | 1 | 1993 | 366 | 0.010 |
Why?
|
| Atmospheric Pressure | 1 | 1991 | 5 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1972 | 302 | 0.010 |
Why?
|
| Porosity | 1 | 1991 | 39 | 0.010 |
Why?
|
| Diffusion | 1 | 1991 | 58 | 0.010 |
Why?
|
| Dextrans | 1 | 1991 | 45 | 0.010 |
Why?
|
| Research Design | 1 | 1994 | 644 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1996 | 735 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1992 | 80 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1993 | 816 | 0.010 |
Why?
|
| Glucose | 2 | 1972 | 876 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1990 | 54 | 0.010 |
Why?
|
| Cardiomyopathy, Alcoholic | 1 | 1990 | 4 | 0.010 |
Why?
|
| Cardiolipins | 1 | 1990 | 20 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1990 | 41 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1990 | 382 | 0.010 |
Why?
|
| Saliva | 1 | 1990 | 114 | 0.010 |
Why?
|
| Models, Biological | 1 | 1974 | 1435 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1989 | 8 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1989 | 8 | 0.010 |
Why?
|
| Shoulder Joint | 1 | 1989 | 24 | 0.000 |
Why?
|
| Organ Size | 1 | 1989 | 411 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1975 | 822 | 0.000 |
Why?
|
| Opportunistic Infections | 1 | 1988 | 78 | 0.000 |
Why?
|
| Carbohydrate Metabolism | 1 | 1987 | 54 | 0.000 |
Why?
|
| Aspergillus fumigatus | 1 | 1987 | 41 | 0.000 |
Why?
|
| Aspergillus | 1 | 1987 | 31 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1990 | 247 | 0.000 |
Why?
|
| Eye Diseases | 1 | 1987 | 112 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1975 | 1679 | 0.000 |
Why?
|
| Reoperation | 1 | 1989 | 771 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1988 | 375 | 0.000 |
Why?
|
| Convalescence | 1 | 1985 | 5 | 0.000 |
Why?
|
| Egtazic Acid | 1 | 1985 | 25 | 0.000 |
Why?
|
| Phospholipids | 1 | 1986 | 107 | 0.000 |
Why?
|
| Boston | 1 | 1965 | 110 | 0.000 |
Why?
|
| Neck | 1 | 1986 | 133 | 0.000 |
Why?
|
| Trachea | 2 | 1978 | 197 | 0.000 |
Why?
|
| Animals, Suckling | 1 | 1984 | 50 | 0.000 |
Why?
|
| Ruthenium Red | 1 | 1984 | 3 | 0.000 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1983 | 3 | 0.000 |
Why?
|
| Technetium | 1 | 1983 | 14 | 0.000 |
Why?
|
| Diphosphonates | 1 | 1983 | 37 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1983 | 229 | 0.000 |
Why?
|
| History, 17th Century | 1 | 1962 | 34 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1990 | 999 | 0.000 |
Why?
|
| Platelet Count | 1 | 1983 | 130 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1984 | 463 | 0.000 |
Why?
|
| Counterimmunoelectrophoresis | 1 | 1981 | 4 | 0.000 |
Why?
|
| Agglutination Tests | 1 | 1981 | 9 | 0.000 |
Why?
|
| Pasteurella | 1 | 1980 | 1 | 0.000 |
Why?
|
| Strongyloides | 1 | 1980 | 16 | 0.000 |
Why?
|
| Bites and Stings | 1 | 1980 | 30 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1990 | 1200 | 0.000 |
Why?
|
| Postgastrectomy Syndromes | 1 | 1979 | 2 | 0.000 |
Why?
|
| Nocardia asteroides | 1 | 1979 | 2 | 0.000 |
Why?
|
| Sphenoid Sinus | 1 | 1979 | 12 | 0.000 |
Why?
|
| Malabsorption Syndromes | 1 | 1979 | 38 | 0.000 |
Why?
|
| Histiocytes | 1 | 1979 | 23 | 0.000 |
Why?
|
| Mastoiditis | 1 | 1979 | 31 | 0.000 |
Why?
|
| Plasma Cells | 1 | 1979 | 47 | 0.000 |
Why?
|
| Acidosis | 1 | 1980 | 92 | 0.000 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 1979 | 58 | 0.000 |
Why?
|
| Influenza A virus | 1 | 1980 | 134 | 0.000 |
Why?
|
| Blood Coagulation Disorders | 1 | 1980 | 101 | 0.000 |
Why?
|
| Abdominal Injuries | 1 | 1979 | 108 | 0.000 |
Why?
|
| Palatine Tonsil | 1 | 1978 | 35 | 0.000 |
Why?
|
| Pseudomonas fluorescens | 1 | 1978 | 1 | 0.000 |
Why?
|
| Simplexvirus | 1 | 1978 | 110 | 0.000 |
Why?
|
| Listeria | 1 | 1977 | 1 | 0.000 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1977 | 42 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1983 | 1312 | 0.000 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1977 | 33 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1979 | 981 | 0.000 |
Why?
|
| Organoids | 1 | 1979 | 276 | 0.000 |
Why?
|
| Klebsiella | 1 | 1976 | 9 | 0.000 |
Why?
|
| Crystallization | 1 | 1976 | 81 | 0.000 |
Why?
|
| Calcium Chloride | 1 | 1976 | 22 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1980 | 1103 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1976 | 173 | 0.000 |
Why?
|
| Risk | 1 | 1978 | 743 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1976 | 97 | 0.000 |
Why?
|
| Proctoscopy | 1 | 1975 | 6 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1975 | 58 | 0.000 |
Why?
|
| Ulcer | 1 | 1975 | 41 | 0.000 |
Why?
|
| Perineum | 1 | 1975 | 48 | 0.000 |
Why?
|
| Rectum | 1 | 1975 | 97 | 0.000 |
Why?
|
| Freund's Adjuvant | 1 | 1972 | 26 | 0.000 |
Why?
|
| Cell Count | 1 | 1972 | 250 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1972 | 443 | 0.000 |
Why?
|